763 related articles for article (PubMed ID: 14580334)
21. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
[TBL] [Abstract][Full Text] [Related]
22. Elucidation of Smad requirement in transforming growth factor-beta type I receptor-induced responses.
Itoh S; Thorikay M; Kowanetz M; Moustakas A; Itoh F; Heldin CH; ten Dijke P
J Biol Chem; 2003 Feb; 278(6):3751-61. PubMed ID: 12446693
[TBL] [Abstract][Full Text] [Related]
23. Expression of vascular endothelial growth factor is coordinately regulated by the activin-like kinase receptors 1 and 5 in endothelial cells.
Shao ES; Lin L; Yao Y; Boström KI
Blood; 2009 Sep; 114(10):2197-206. PubMed ID: 19506300
[TBL] [Abstract][Full Text] [Related]
24. ALK5 phosphorylation of the endoglin cytoplasmic domain regulates Smad1/5/8 signaling and endothelial cell migration.
Ray BN; Lee NY; How T; Blobe GC
Carcinogenesis; 2010 Mar; 31(3):435-41. PubMed ID: 20042635
[TBL] [Abstract][Full Text] [Related]
25. A direct interaction between TGFbeta activated kinase 1 and the TGFbeta type II receptor: implications for TGFbeta signalling and cardiac hypertrophy.
Watkins SJ; Jonker L; Arthur HM
Cardiovasc Res; 2006 Feb; 69(2):432-9. PubMed ID: 16360132
[TBL] [Abstract][Full Text] [Related]
26. Defective paracrine signalling by TGFbeta in yolk sac vasculature of endoglin mutant mice: a paradigm for hereditary haemorrhagic telangiectasia.
Carvalho RL; Jonker L; Goumans MJ; Larsson J; Bouwman P; Karlsson S; Dijke PT; Arthur HM; Mummery CL
Development; 2004 Dec; 131(24):6237-47. PubMed ID: 15548578
[TBL] [Abstract][Full Text] [Related]
27. Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2.
Macías-Silva M; Hoodless PA; Tang SJ; Buchwald M; Wrana JL
J Biol Chem; 1998 Oct; 273(40):25628-36. PubMed ID: 9748228
[TBL] [Abstract][Full Text] [Related]
28. ALK1 regulates the internalization of endoglin and the type III TGF-β receptor.
Tazat K; Pomeraniec-Abudy L; Hector-Greene M; Szilágyi SS; Sharma S; Cai EM; Corona AL; Ehrlich M; Blobe GC; Henis YI
Mol Biol Cell; 2021 Apr; 32(7):605-621. PubMed ID: 33566682
[TBL] [Abstract][Full Text] [Related]
29. Activin receptor-like kinase 2 and Smad6 regulate epithelial-mesenchymal transformation during cardiac valve formation.
Desgrosellier JS; Mundell NA; McDonnell MA; Moses HL; Barnett JV
Dev Biol; 2005 Apr; 280(1):201-10. PubMed ID: 15766759
[TBL] [Abstract][Full Text] [Related]
30. TGFbeta-stimulated Smad1/5 phosphorylation requires the ALK5 L45 loop and mediates the pro-migratory TGFbeta switch.
Liu IM; Schilling SH; Knouse KA; Choy L; Derynck R; Wang XF
EMBO J; 2009 Jan; 28(2):88-98. PubMed ID: 19096363
[TBL] [Abstract][Full Text] [Related]
31. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
[TBL] [Abstract][Full Text] [Related]
32. TGFbeta-mediated activation of Smad1 in B-cell non-Hodgkin's lymphoma and effect on cell proliferation.
Munoz O; Fend F; de Beaumont R; Husson H; Astier A; Freedman AS
Leukemia; 2004 Dec; 18(12):2015-25. PubMed ID: 15470494
[TBL] [Abstract][Full Text] [Related]
33. SnoN facilitates ALK1-Smad1/5 signaling during embryonic angiogenesis.
Zhu Q; Kim YH; Wang D; Oh SP; Luo K
J Cell Biol; 2013 Sep; 202(6):937-50. PubMed ID: 24019535
[TBL] [Abstract][Full Text] [Related]
34. Transforming growth factor (TGF-beta)-specific signaling by chimeric TGF-beta type II receptor with intracellular domain of activin type IIB receptor.
Persson U; Souchelnytskyi S; Franzén P; Miyazono K; ten Dijke P; Heldin CH
J Biol Chem; 1997 Aug; 272(34):21187-94. PubMed ID: 9261125
[TBL] [Abstract][Full Text] [Related]
35. Endoglin differentially modulates antagonistic transforming growth factor-beta1 and BMP-7 signaling.
Scherner O; Meurer SK; Tihaa L; Gressner AM; Weiskirchen R
J Biol Chem; 2007 May; 282(19):13934-43. PubMed ID: 17376778
[TBL] [Abstract][Full Text] [Related]
36. TGFβ1-induced SMAD2/3 and SMAD1/5 phosphorylation are both ALK5-kinase-dependent in primary chondrocytes and mediated by TAK1 kinase activity.
van Caam A; Madej W; Garcia de Vinuesa A; Goumans MJ; Ten Dijke P; Blaney Davidson E; van der Kraan P
Arthritis Res Ther; 2017 May; 19(1):112. PubMed ID: 28569204
[TBL] [Abstract][Full Text] [Related]
37. Transforming growth factor-beta (TGF-beta) type I receptor/ALK5-dependent activation of the GADD45beta gene mediates the induction of biglycan expression by TGF-beta.
Ungefroren H; Groth S; Ruhnke M; Kalthoff H; Fändrich F
J Biol Chem; 2005 Jan; 280(4):2644-52. PubMed ID: 15546867
[TBL] [Abstract][Full Text] [Related]
38. The orphan receptor serine/threonine kinase ALK7 signals arrest of proliferation and morphological differentiation in a neuronal cell line.
Jörnvall H; Blokzijl A; ten Dijke P; Ibáñez CF
J Biol Chem; 2001 Feb; 276(7):5140-6. PubMed ID: 11084022
[TBL] [Abstract][Full Text] [Related]
39. SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7.
DaCosta Byfield S; Major C; Laping NJ; Roberts AB
Mol Pharmacol; 2004 Mar; 65(3):744-52. PubMed ID: 14978253
[TBL] [Abstract][Full Text] [Related]
40. TGFbeta1 induces vasculogenesis and inhibits angiogenic sprouting in an embryonic stem cell differentiation model: respective contribution of ALK1 and ALK5.
Mallet C; Vittet D; Feige JJ; Bailly S
Stem Cells; 2006 Nov; 24(11):2420-7. PubMed ID: 17071858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
